These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 19950594)

  • 1. [Effects of combined use of dofetilide and verapamil on the action potential of papillary muscles in guinea pigs].
    Li ML; Zeng XR; Yang Y; Du JR
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 40(5):834-8. PubMed ID: 19950594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency dependent prolongation of effective refractory period by a complex class III antiarrhythmic agent CPU-86017.
    Li HT; Wang YQ; Dai DZ; Kong RZ
    Acta Pharmacol Sin; 2001 Jan; 22(1):32-6. PubMed ID: 11730558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential rate and potassium-dependent effects of the class III agents d-sotalol and dofetilide on guinea pig papillary muscle.
    Marschang H; Beyer T; Karolyi L; Kübler W; Brachmann J
    Cardiovasc Drugs Ther; 1998 Dec; 12(6):573-83. PubMed ID: 10410827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of dauricine on early afterdepolarizations and L-type calcium current.
    Liu QN; Zhang L; Gong PL; Yang XY; Zeng FD
    Can J Physiol Pharmacol; 2009 Nov; 87(11):954-62. PubMed ID: 19935903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of altered extracellular potassium and pacing cycle length on the class III antiarrhythmic actions of dofetilide (UK-68,798) in guinea-pig papillary muscle.
    Yang T; Tande PM; Lathrop DA; Refsum H
    Cardiovasc Drugs Ther; 1992 Aug; 6(4):429-36. PubMed ID: 1520650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-adrenoceptor activation plays a role in the reverse rate-dependency of effective refractory period lengthening by dofetilide in the guinea-pig atrium, in vitro.
    Kovács A; Magyar J; Bányász T; Nánási PP; Szénási G
    Br J Pharmacol; 2003 Aug; 139(8):1555-63. PubMed ID: 12922944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency dependence in the action of the class III antiarrhythmic drug dofetilide is modulated by altering L-type calcium current and digitalis glucoside.
    Gjini V; Schreieck J; Korth M; Weyerbrock S; Schömig A; Schmitt C
    J Cardiovasc Pharmacol; 1998 Jan; 31(1):95-100. PubMed ID: 9456283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KCB-328: a novel class III antiarrhythmic agent with little reverse frequency dependence in isolated guinea pig myocardium.
    Lee K; Lee JY; Kim HY; Kwon LS; Shin HS; Tanabe S; Kozono T; Park SD; Chung YS
    J Cardiovasc Pharmacol; 1998 Apr; 31(4):609-17. PubMed ID: 9554812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined potassium and calcium channel antagonistic activities as a basis for neutral frequency dependent increase in action potential duration: comparison between BRL-32872 and azimilide.
    Bril A; Forest MC; Cheval B; Faivre JF
    Cardiovasc Res; 1998 Jan; 37(1):130-40. PubMed ID: 9539867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effect of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of the new class III antiarrhythmics dofetilide, ambasilide, and chromanol 293B.
    Schreieck J; Wang Y; Gjini V; Korth M; Zrenner B; Schömig A; Schmitt C
    J Cardiovasc Electrophysiol; 1997 Dec; 8(12):1420-30. PubMed ID: 9436780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Class III effects of dofetilide and arrhythmias are modulated by [K+]o in an in vitro model of simulated-ischemia and reperfusion in guinea-pig ventricular myocardium.
    Ducroq J; Rouet R; Sallé L; Puddu PE; Repessé Y; Ghadanfar M; Ducouret P; Gérard JL
    Eur J Pharmacol; 2006 Feb; 532(3):279-89. PubMed ID: 16480976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiological effects of resveratrol on guinea pig papillary muscles.
    Zhao J; Ma HJ; Dong JH; Zhang LP; Liu HL; Wang QS
    Sheng Li Xue Bao; 2004 Dec; 56(6):708-12. PubMed ID: 15614419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Class III antiarrhythmic action by potassium channel blockade: dofetilide attenuates hypoxia induced electromechanical changes.
    Yang T; Tande PM; Lathrop DA; Refsum H
    Cardiovasc Res; 1992 Nov; 26(11):1109-15. PubMed ID: 1291089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiological characterization of class III activity of a verapamil derivative in guinea-pig cardiac tissues.
    Kammer T; Berger F; Borchard U; Hafner D
    Arzneimittelforschung; 1993 Mar; 43(3):302-8. PubMed ID: 8489557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential recovery of action potential duration and HERG currents from the effects of two methanesulfonamide class III antiarrhythmic agents, KCB-328 and dofetilide.
    Lee K; Park JB; Jeon BH; Kim KJ; Ryu PD; Kwon LS; Kim HY
    J Cardiovasc Pharmacol; 2003 Nov; 42(5):648-55. PubMed ID: 14576514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dofetilide promotes repolarization abnormalities in perfused Guinea-pig heart.
    Osadchii OE
    Cardiovasc Drugs Ther; 2012 Dec; 26(6):489-500. PubMed ID: 22918600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiological effects of dofetilide in an in vitro model of "border zone" between normal and ischemic/reperfused myocardium.
    Rouet R; Picard S; Libersa C; Ghadanfar M; Alabaster C; Gérard JL
    Circulation; 2000 Jan 4-11; 101(1):86-93. PubMed ID: 10618309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of guinea-pig ventricular myocytes and dog Purkinje fibres for in vitro assessment of drug-induced delayed repolarization.
    Terrar DA; Wilson CM; Graham SG; Bryant SM; Heath BM
    J Pharmacol Toxicol Methods; 2007; 56(2):171-85. PubMed ID: 17596973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of EGIS-7229 (S 21407), a novel class III antiarrhythmic drug, on myocardial refractoriness to electrical stimulation in vivo and in vitro.
    Kovács A; Gyönös I; Magyar J; Bányász T; Nánási PP; Spedding M; Szénási G
    J Cardiovasc Pharmacol; 2001 Jan; 37(1):78-88. PubMed ID: 11152377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarrhythmic effect of the Ca
    Kirchhoff JE; Diness JG; Abildgaard L; Sheykhzade M; Grunnet M; Jespersen T
    Pflugers Arch; 2016 Nov; 468(11-12):1853-1863. PubMed ID: 27722784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.